Pansy, K; Fechter, K; Wenzl, K; Arra, A; Novak, JP; Szmyra, M; Haingartner, S; Ramsay, AG; Novak, AJ; Greinix, HT; Beham-Schmid, C; Neumeister, P; Deutsch, AJA
Loss of Nr4a1 Causes an Elevated Expression of Co-Inhibitory Receptor:Ligand Axes and Results in a Diminished T Cell-Mediated Lymphoma Cell Killing in Aggressive Lymphoma
BLOOD. 2022; 140: 2038-2039.-64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH); DEC 10-13, 2022; New Orleans, LA.
Doi: 10.1182/blood-2022-163034
[Poster]
Web of Science
FullText
FullText_MUG
Pansy, K; Fechter, K; Kargl, J; Wenzl, K; Prochazka, K; Greinix, H; Haybaeck, J; Prokesch, A; Beham-Schmid, C; Feichtinger, J; Neumeister, P; Deutsch, A
Nr4a1 is implicated in the regulation of immune checkpoints in aggressive lymphomas
ONCOL RES TREAT. 2019; 42: 135-135.
[Oral Communication]
Web of Science
Pansy, K; Fechter, K; Kargl, J; Wenzl, K; Prochazka, K; Greinix, H; Haybaeck, J; Prokesch, A; Beham-Schmid, C; Feichtinger, J; Neumeister, P; Deutsch, A;
Tumor suppressive function of Nr4a1 is mediated by regulation of Pd1-Pdl1-Pdl2 and Ctla4-Cd80-Cd86 axis in aggressive lymphomas
ÖGMBT Annual Meeting; SEP 16-18, 2019; Salzburg, AUSTRIA. 2019.
[Oral Communication]
Pansy, K; Fechter, K; Kargl, J; Wenzl, K; Prochazka, K; Greinix, H; Haybaeck,J; Prokesch, A; Beham-Schmid, C; Feichtinger, J; Neumeister, P; Deutsch, AJ;
Tumor suppressive function of Nr4a1 is mediated by the regulation of immune checkpoints in aggressive lymphomas
ÖGAI Annual Meeting; NOV 21-23; 2019; Graz, AUSTRIA. 2019.
[Oral Communication]
Pansy, K; Fechter, K; Wenzl, K; Greinix, H; Prochazka, K; Haybäck, J; Prokesch, A; Feichtinger, J; Neumeister, P; Deutsch, A
Nr4a1 is implicated in immune escape by regulating the Pd1-Pdl1-Pdl2 and Ctla4-Cd80-Cd86 axis in aggressive lymphomas
OeGHO- & AHOP-Frühjahrstagung 2019; APR 11-13, 2019; Linz. 2019.
[Poster]
Uhl, B; Prochazka, K; Wenzl, K; Hatzl, S; Greinix, HT; Beham-Schmid, C; Neumeister, P; Deutsch, A
Differences of the chemokine receptor expression profile of aggressive lymphoma and GCB-cells and probable influence on clinical outcome
ONCOL RES TREAT. 2019; 42: 83-83.
[Poster]
Web of Science
Fechter, K; Wenzl, K; Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A
LOSS OF NR4A1 ACCELERATES MYC-DRIVEN LYMPHOMAGENESIS ACCOMPANIED BY OVEREXPRESSION OF GENES INVOLVED IN IMMUNOREGULATION.
HAEMATOLOGICA. 2017; 102: 560-561.-22nd Congress of the European-Hematology-Association; JUN 22-25, 2017; Madrid, SPAIN.
[Oral Communication]
Web of Science
Fechter, K; Wenzl, K; Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A
Loss of Nr4a1 accelerates Myc-driven lymphomagenesis and alters the composition of immune cells in the tumor microenvironment
ONCOL RES TREAT. 2017; 40: 108-108.
[Poster]
Web of Science
Uhl, B; Wenzl, K; Fechter, K; Prochazka, KT; Beham-Schmid, C; Greinix, HT; Neumeister, P; Deutsch, A;
CCR7 expression is associated to favourable cancer specific survival of aggressive lymphoma patients.
OeGHO Frühjahrstagung 2017; APR 6-8, 2017; Bregenz, AUSTRIA. 2017.
[Poster]
Deutsch, A; Rinner, B; Wenzl, K; Troppan, K; Pursche, B; Beham-Schmid, C; Neumeister, P
NR4A1 AND NR4A3 POSSESS FUNCTIONAL REDUNDANCY BY REGULATING PRO-APOPTOTIC GENES IN AGGRESSIVE LYMPHOMAS.
HAEMATOLOGICA. 2015; 100: 544-544.-20th Congress of European-Hematology-Association; JUN 11-14, 2015; Vienna, AUSTRIA.
[Poster]
Web of Science
Deutsch, AJA; Rinner, B; Wenzl, K; Troppan, K; Pursche, B; Greinix, HT; Beham-Schmid, C; Neumeister, P
NR4A3 Possesses Tumor Suppressive Properties like NR4A1 By Regulating Pro-Apoptotic Genes in Aggressive Lymphomas and Serves As a Potential Drug Target for Lymphoma Therapy
BLOOD. 2015; 126(23):-57th Annual Meeting of the American-Society-of-Hematology; DEC 05-08, 2015; Orlando, FL.
[Poster]
Web of Science
Troopan, K; Wenzl, K; Pichler, M; Pursche, B; Schwarzenbacher, D; Feichtinger, J; Thallinger, G; Beham-Schmid, C; Neumeister, P; Deutsch, A
MiR-199a and miR-497 are associated with better overall survival due to increased chemosensitivity in aggressive non-Hodgkin's lymphoma patients
ONCOL RES TREAT. 2015; 38: 63-64.
[Poster]
Web of Science
Troppan K, Wenzl K, Neumeister P, Beham-Schmid C, Przekopowitz M, Greinix H, H Schaider, Deutsch AJA
The chemokine receptor profile as distinctive criterion between normal B-cell subsets and as potential discriminative marker to identify the cell of origin in patients with chronic
lymphocytic leukemia and Richter syndrome
57th ASH Annual Meeting. 2015; -57th ASH Annual Meeting; DEC 5-8; Orlando, USA.
[Poster]
Troppan, K; Wenzl, K; Neumeister, P; Beham-Schmid, C; Przekopowitz, M; Greinix, HT; Schaider, H; Deutsch, AJA
The Chemokine Receptor Profile As Distinctive Criterion Between Normal B-Cell Subsets and As Potential Discriminative Marker to Identify the Cell of Origin in Patients with Chronic Lymphocytic Leukemia and Richter Syndrome
BLOOD. 2015; 126(23):-55th Annual Meeting and Exposition of the American-Society-of-Hematology; DEC 07-10, 2013; New Orleans, LA.
[Poster]
Web of Science
Wenzl, K; Troppan, K; Pursche, B; Bischof, M; Beham-Schmid, C; Greinix, HT; Neumeister, P; Deutsch, AJA
Loss of NR4A1 Accelerates the Development of Aggressive Lymphomas in Myc Induced Cancerogenesis
BLOOD. 2015; 126(23):-57th Annual Meeting of the American-Society-of-Hematology; DEC 05-08, 2015; Orlando, FL.
[Poster]
Web of Science
Deutsch, A; Rinner, B; Wenzl, K; Troppan, K; Beham-Schmid, C; Neumeister, P
NR4A3-MEDIATED APOPTOSIS SUPPRESSES LYMPHOMAGENESIS IN A XENOGRAFT MOUSE MODEL
HAEMATOLOGICA. .. 2014; 99: 136-136.-19th Congress of the European-Hematology-Association; JUN 12-15, 2014; Milan, ITALY.
[Poster]
Web of Science
Troppan, K; Wenzl, K; Deutsch, A; Pichler, M; Graupp, M; Beham-Schmid, C; Neumeister, P
HIGH EXPRESSION OF MIRNA-199A_1 AND MIRNA-497_1 IS ASSOCIATED WITH BETTER OVERALL SURVIVAL IN AGGRESSIVE NON-HODGKIN'S LYMPHOMA
HAEMATOLOGICA. 2014; 99: 135-135.
[Poster]
Web of Science
Troppan K; Wenzl K; Deutsch A; Schwarzenbacher D; Pichler M; Graupp M; Neumeister P
Hohe Expression von microRNA-199a_1 und microRNA-497_1 ist assoziiert mit besserem Überleben bei patienten mit aggressivem non-Hodgkin-Lymphom
Memo magazine of european medical oncology
Proceedings of the annual meeting of the Austrian society of haematology and medical oncology. 2014; 7(1):14-15.-Frühjahrstagung ÖGHO; APR 10-12, 2014; Innsbruck.
[Poster]
Troppan, KT; Wenzl, K; Pursche, B; Schaider, H; Beham-Schmid, C; Deutsch, A; Neumeister, P
Distinct chemokine receptor profiles in Richter's transformation compared to de-novo diffuse large B-cell lymphoma and germinal center B-cells
ONCOL RES TREAT. 2014; 37: 72-73.
[Poster]
Web of Science
Wenzl, K; Troppan, K; Deutsch, A; Neumeister, P
ANALYSES OF NUCLEAR ORPHAN RECEPTOR EXPRESSION AND CYTOTOXICITY FOLLOWING ANTI-CD 20 MONOCLONAL ANTIBODY TREATMENT IN AGGRESSIVE NON-HODGKIN'S LYMPHOMAS
HAEMATOLOGICA. 2014; 99: 685-686.-19th Congress of the European-Hematology-Association; JUN 12-15, 2014; Milan, ITALY.
[Poster]
Web of Science
Wenzl, K; Troppan, K; Pursche, B; Schaider, H; Beham-Schmid, C; Deutsch, A; Neumeister, P
Patients with aggressive B-cell lymphomas display distinct chemokine receptor profile and an association of low CCR7 expression and favorable cancer specific survival
ONCOL RES TREAT. 2014; 37: 73-73.
[Poster]
Web of Science
Wenzl, K; Troppan, K; Deutsch, AJA, Linkesch, W; Neumeister, P, Beham-Schmid, C
Distinct Chemokine Receptor Profile In Chronic Lymphocytic Leukaemia and Richter Transformed Diffuse Large B Cell Lymphomas Compared To Germinal Center B Cells and De Novo Diffuse Large B Cell Lymphomas
Proceedings of 55th ASH Annual Meeting. 2013; -55th ASH Annual Meeting; December 7-10, 2013 ; New Orleans.
FullText
Wenzl, K; Troppan, K; Deutsch, AJA; Linkesch, W; Neumeister, P; Beham-Schmid, C;
Distinct Chemokine Receptor Profile In Chronic Lymphocytic Leukaemia and Richter Transformed Diffuse Large B Cell Lymphomas Compared To Germinal Center B Cells and De Novo Diffuse Large B Cell Lymphomas.
BLOOD. BLOOD122: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 55th Annual Meeting of the American-Society-of-Hematology, New Orleans, LA, DEC 07-10, 2013)
Doi: 10.1182/blood.V122.21.4852.4852
Web of Science
FullText
FullText_MUG